Evidence map›Paper›PMID 40922953›Full record

ArticleBioImpacts : BI2025

Photoplethysmography based non-invasive blood glucose estimation using systolic-diastolic framing MFCC features and machine learning regression.

Ali Kermani, Hossein Esmaeili

Abstract read
In one paragraph

Article in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ali KermaniElectrical & Computer Engineering Department, University of Science & Technology of Mazandaran, Behshahr, Iran.ORCID https://orcid.org/0000-0001-9298-7970
Hossein EsmaeiliElectrical Department, Shahrood University of Technology, Shahrood, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Accurate and non-invasive blood glucose estimation is essential for effective health monitoring. Traditional methods are invasive and inconvenient, often leading to poor patient compliance. This study introduces a novel approach that leverages systolic-diastolic framing Mel-frequency cepstral coefficients (SDFMFCC) to enhance the accuracy and reliability of blood glucose estimation using photoplethysmography (PPG) signals. Methods: The proposed method employs SDFMFCC for feature extraction, incorporating systolic and diastolic frames. The systolic and diastolic points are identified using the Savitzky-Golay filter, followed by local extrema detection. Blood glucose levels are estimated using support vector regression (SVR). The evaluation is performed on a dataset comprising 67 raw PPG signal samples, along with labeled demographic and biometric data collected from 23 volunteers (aged 20 to 60 years) under informed consent and ethical guidelines. Results: The SDFMFCC-based approach demonstrates high accuracy (99.8%) and precision (0.996), with a competitive root mean square error (RMSE) of 26.01 mg/dL. The Clarke Error Grid analysis indicates that 99.273% of predictions fall within Zone A, suggesting clinically insignificant differences between estimated and actual glucose levels. Conclusion: The study validates the hypothesis that incorporating a new framing method in MFCC feature extraction significantly enhances the accuracy and reliability of non-invasive blood glucose estimation. The results highlight that the SDFMFCC method effectively captures critical physiological variations in PPG signals, offering a promising alternative to traditional invasive methods.

Indexed as

Machine learning regressionMFCCNon-invasive glucose estimationPPGSystolic-diastolic

Identifiers

PMID40922953
PMCPMC12413980

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.